Breaking News Instant updates and real-time market news.

HALO

Halozyme

$12.24

0.16 (1.32%)

07:48
10/04/16
10/04
07:48
10/04/16
07:48

Halozyme drug, companion assay chosen for pancreatic cancer trial initiative

Halozyme Therapeutics announced that its investigational drug, PEGPH20, and a companion diagnostic assay for assessment of hyaluronan under development by Ventana Medical Systems will be included in a pancreatic cancer clinical trial initiative called Precision Promise. The Precision Promise initiative aims to change the current treatment approach to pancreatic cancer, offering options to patients based on the molecular profile of their tumor. Precision Promise plans to enroll patients at 12 initial consortium sites in Spring 2017.

HALO Halozyme
$12.24

0.16 (1.32%)

01/20/16
UBSW
01/20/16
NO CHANGE
Target $22
UBSW
Buy
Halozyme price target lowered to $22 from $28 at UBS
UBS lowered its price target on Halozyme to $22 from $28 due to the recent market weakness in the biotech sector. The firm said the company's recent data on its drug was not well received, but still suggests a potential new standard of care in pancreatic cancer. UBS maintained its Buy rating on Halozyme shares.
02/01/16
ADAM
02/01/16
INITIATION
Target $10
ADAM
Buy
Halozyme initiated with a Buy at Canaccord
Target $10.
02/01/16
02/01/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acadia (ACHC) initiated with an Overweight at KeyBanc... Altisource Residential (RESI) initiated with a Neutral at Nomura... Colony Starwood Homes (SFR) initiated with a Buy at Nomura... EyeGate (EYEG) initiated with a Buy at Rodman & Renshaw... Fortinet (FTNT) initiated with an Outperform at Northland... Halozyme (HALO) initiated with a Buy at Canaccord... Lendingtree (TREE) initiated with an Outperform at Northland... Lindblad Expeditions (LIND) initiated with an Outperform at Credit Suisse... Summit Therapeutics (SMMT) initiated with a Buy at Canaccord... VolitionRx (VNRX) initiated with a Buy at Rodman & Renshaw.
09/16/16
PIPR
09/16/16
NO CHANGE
Target $18
PIPR
Overweight
Halozyme price target raised to $18 from $15 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised his price target for Halozyme Therapeutics to $18 after hosting investor meetings with management. The analyst now has increased conviction in the long-term value of the company's ENHANZE products. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ATH

Athene Holding

10:23
12/09/16
12/09
10:23
12/09/16
10:23
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ICHR

Ichor Holdings

10:23
12/09/16
12/09
10:23
12/09/16
10:23
Syndicate
Ichor Holdings indicated to open at $9.75, IPO priced at $9.00 »

Ichor Holdings (ICHR)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CPB

Campbell Soup

$59.00

0.72 (1.24%)

10:21
12/09/16
12/09
10:21
12/09/16
10:21
Options
Campbell Soup calls are stirring »

Campbell Soup calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

Restoration Hardware

$32.75

-6.24 (-16.00%)

10:20
12/09/16
12/09
10:20
12/09/16
10:20
Options
Restoration Hardware options active as shares fall on earnings »

Restoration Hardware…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

10:20
12/09/16
12/09
10:20
12/09/16
10:20
General news
Treasury Action: yields remained subdued »

Treasury Action: yields…

CPK

Chesapeake Utilities

$68.55

0.55 (0.81%)

, CNX

CONSOL

$21.16

-0.62 (-2.85%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CPK

Chesapeake Utilities

$68.55

0.55 (0.81%)

CNX

CONSOL

$21.16

-0.62 (-2.85%)

JCI

Johnson Controls

$43.68

0.03 (0.07%)

AMID

American Midstream Partners

$16.95

-0.05 (-0.29%)

BIP

Brookfield Infrastructure

$32.93

0.2499 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ANF

Abercrombie & Fitch

$15.96

-0.28 (-1.72%)

, DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

ANF

Abercrombie & Fitch

$15.96

-0.28 (-1.72%)

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

HLT

Hilton

$26.54

0.295 (1.12%)

HZNP

Horizon Pharma

$15.03

-4.36 (-22.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 14

    Dec

AZN

AstraZeneca

$27.11

0.84 (3.20%)

, ADSK

Autodesk

$81.74

1.4 (1.74%)

10:19
12/09/16
12/09
10:19
12/09/16
10:19
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

AZN

AstraZeneca

$27.11

0.84 (3.20%)

ADSK

Autodesk

$81.74

1.4 (1.74%)

ETN

Eaton

$69.45

0.47 (0.68%)

FLR

Fluor

$56.77

0.77 (1.38%)

SYY

Sysco

$54.46

0.13 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 16

    Feb

$NYE

NYSE Market Internals

10:16
12/09/16
12/09
10:16
12/09/16
10:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

10:16
12/09/16
12/09
10:16
12/09/16
10:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:15
12/09/16
12/09
10:15
12/09/16
10:15
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

10:15
12/09/16
12/09
10:15
12/09/16
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

SDRL

Seadrill

$3.72

0.315 (9.26%)

10:14
12/09/16
12/09
10:14
12/09/16
10:14
Options
Seadrill calls active as shares rally »

Seadrill calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VHC

VirnetX

$3.35

0.05 (1.52%)

10:12
12/09/16
12/09
10:12
12/09/16
10:12
Periodicals
Breaking Periodicals news story on VirnetX »

Appeals court affirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:10
12/09/16
12/09
10:10
12/09/16
10:10
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

XLF

Financial Select Sector

$23.63

-0.07 (-0.30%)

10:10
12/09/16
12/09
10:10
12/09/16
10:10
Options
$15.9M premium block in SPDR Financials »

$15.9M premium block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
12/09/16
12/09
10:10
12/09/16
10:10
General news
U.S. December consumer sentiment surged 4.2 points to 98.0 in preliminary »

U.S. December consumer…

TEX

Terex

$32.28

-0.06 (-0.19%)

10:09
12/09/16
12/09
10:09
12/09/16
10:09
Upgrade
Terex rating change  »

Terex upgraded to Mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AZN

AstraZeneca

$27.09

0.82 (3.12%)

10:08
12/09/16
12/09
10:08
12/09/16
10:08
Hot Stocks
FDA accepts BLA for AstraZeneca's durvalumab for bladder cancer »

AstraZeneca and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

KO

Coca-Cola

$41.82

0.835 (2.04%)

10:04
12/09/16
12/09
10:04
12/09/16
10:04
Technical Analysis
Coca-Cola tests downtrend resistance »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

10:01
12/09/16
12/09
10:01
12/09/16
10:01
General news
Wholesale Trade Inventories data reported »

October Wholesale Trade…

10:01
12/09/16
12/09
10:01
12/09/16
10:01
General news
Consumer Sentiment Index data reported »

Consumer Sentiment Index…

LVS

Las Vegas Sands

$56.77

2.1 (3.84%)

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Options
Sweep call buyer in LVS »

Sweep call buyer in LVS.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATH

Athene Holding

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Syndicate
Breaking Syndicate news story on Athene Holding »

Athene Holding indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CFX

Colfax

$39.53

0.25 (0.64%)

10:00
12/09/16
12/09
10:00
12/09/16
10:00
Options
Colfax Dec 40 calls trade for 65 and 70c »

Colfax Dec 40 calls trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.